HOST RANGE DIVERSITY OF BACTERIOPHAGE FOR Y. PESTIS

鼠疫杆菌噬菌体的宿主范围多样性

基本信息

  • 批准号:
    7107657
  • 负责人:
  • 金额:
    $ 49.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-05-01 至 2007-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Yersinia pestis, the bacterium responsible for plague, is a Category A pathogen, a significant biowarfare agent. If weaponized, it can easily gain direct access to the respiratory system to cause rapid death by pneumonic plague. Pneumonic plague has fatality rates over 50%, is highly contagious, and if the bacteria are engineered to resist antibiotics, is essentially unbeatable. As a countermeasure to such a threat, we propose to develop a library of bacteriophages ("phages") specific for Y. pestis that can kill multiple strains of this bacterium in a highly efficient manner. AvidBiotics has exclusive access to technology to generate families of phage with highly diverse tails capable of binding to mutant forms of bacteria, such as Bordetella. In this application, we propose to develop a library of phage to bind to, infect and kill mutant Y. pestis bacteria, anticipating potential mutations engineered into the bacteria to change their sensitivities to antibiotics or surface receptors for phage. This technology is based on the discovery of a family of diversity-generating retroelements (DGRs) that function to vary DNA sequences and the proteins they encode. These DGRs can be engineered into phages to diversify specifically the amino acid sequence of the precise receptor-binding site of the phage tail fiber, thereby generating a library of phages with more than a trillion different possible tails targeting Y. pestis cell surface receptors. By exposing such a phage library to mutant or weaponized plague bacteria, phages capable of infecting, multiplying and killing the bacteria could be identified, selected, isolated, amplified, aerosolized and then deployed to protect against or treat infections by weaponized Y. pestis. The objective of this application is to demonstrate the ability to utilize the DGR-system to precisely and extensively diversify the phage tail fiber sequences as a means to create novel phage with broad Y. pestis tropism. These studies will provide the foundation for future studies to generate a suitable, formulated pool of highly diverse phages that will serve as a reliable, productive source of diagnostic and therapeutic agents effective against weaponized plague bacteria. We anticipate that a Phase II follow-on project would entail developing a process to GLP manufacture and formulate representative members of the diverse phage library targeting Y. pestis and conduct pre-clinical safety studies to prepare a rapid response counter- terrorism system to manage pneumonic plague in humans.
描述(由申请人提供):鼠疫耶尔森氏菌(Yersinia pestis)是鼠疫的致病菌,属于A类病原体,是一种重要的生物战剂。如果武器化,它可以很容易地直接进入呼吸系统,导致肺鼠疫迅速死亡。肺鼠疫的死亡率超过50%,具有高度传染性,如果对细菌进行改造以抵抗抗生素,那么它基本上是无与伦比的。作为对这种威胁的对策,我们建议开发一个针对Y.鼠疫杆菌,可以杀死多种菌株的这种细菌以高效的方式。AvidBiotics拥有独家技术,可以产生具有高度多样性尾部的噬菌体家族,这些噬菌体能够与细菌的突变形式结合,例如博德特氏菌。在本申请中,我们提出开发噬菌体库以结合、感染和杀死突变体Y。鼠疫细菌,预计潜在的突变工程到细菌,以改变其敏感性的抗生素或表面受体的噬菌体。这项技术是基于发现一个家庭的多样性产生的逆转录元件(DGRs)的功能,以改变DNA序列和蛋白质,他们编码。这些DGRs可以被工程化到噬菌体尾丝中,以特异性地多样化噬菌体尾丝的精确受体结合位点的氨基酸序列,从而产生具有超过万亿种不同的靶向Y的可能尾的噬菌体文库。鼠疫菌细胞表面受体通过将这样的噬菌体文库暴露于突变的或武器化的鼠疫细菌,可以鉴定、选择、分离、扩增、雾化能够感染、增殖和杀死细菌的细菌,然后部署以防止或治疗由武器化的Y。鼠疫本申请的目的是证明利用DGR系统精确和广泛地使噬菌体尾纤维序列多样化的能力,作为产生具有宽Y的新型噬菌体的手段。鼠疫趋性这些研究将为未来的研究提供基础,以产生一个合适的,配制的高度多样化的细菌,将作为一个可靠的,生产性的诊断和治疗剂的有效来源,对武器化的鼠疫细菌。我们预计,II期后续项目将需要开发GLP生产工艺,并制定靶向Y的多种噬菌体文库的代表性成员。并进行临床前安全研究,以建立一个快速反应的反恐系统,管理人类肺鼠疫。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David William Martin其他文献

David William Martin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David William Martin', 18)}}的其他基金

DIVERSIFYING MICA TO CREATE TARGETED ADAPTERS TO RECRUIT AND ACTIVATE NK CELLS TO
使云母多样化以创建有针对性的适配器来招募和激活 NK 细胞
  • 批准号:
    8455819
  • 财政年份:
    2013
  • 资助金额:
    $ 49.5万
  • 项目类别:
TARGETABLE BACTERICIDAL PROTEINS TO SPECIFICALLY KILL CLOSTRIDIUM DIFFICILE BACTE
特异性杀死艰难梭菌的靶向杀菌蛋白
  • 批准号:
    8549942
  • 财政年份:
    2012
  • 资助金额:
    $ 49.5万
  • 项目类别:
TARGETABLE BACTERICIDAL PROTEINS TO SPECIFICALLY KILL CLOSTRIDIUM DIFFICILE BACTE
特异性杀死艰难梭菌的靶向杀菌蛋白
  • 批准号:
    8250243
  • 财政年份:
    2012
  • 资助金额:
    $ 49.5万
  • 项目类别:
Create, evaluate and develop pre-clinically an engineered R-type pyocin to specif
创建、评估和开发临床前工程 R 型脓毒素,以指定
  • 批准号:
    7908557
  • 财政年份:
    2010
  • 资助金额:
    $ 49.5万
  • 项目类别:
Targeted soluble MICA molecules to recruit innate immunity cells to kill specific
靶向可溶性 MICA 分子招募先天免疫细胞来杀死特定的
  • 批准号:
    7907360
  • 财政年份:
    2010
  • 资助金额:
    $ 49.5万
  • 项目类别:
Create, evaluate and develop pre-clinically an engineered R-type pyocin to specif
创建、评估和开发临床前工程 R 型脓毒素,以指定
  • 批准号:
    8071633
  • 财政年份:
    2010
  • 资助金额:
    $ 49.5万
  • 项目类别:
Targeted soluble MICA molecules to recruit innate immunity cells to kill specific
靶向可溶性 MICA 分子招募先天免疫细胞来杀死特定的
  • 批准号:
    8043656
  • 财政年份:
    2010
  • 资助金额:
    $ 49.5万
  • 项目类别:

相似海外基金

Towards phage therapy: combining genetics and cutting edge CryoEM to optimise a bacterial virus to kill a superbug
迈向噬菌体疗法:结合遗传学和尖端冷冻电镜来优化细菌病毒以杀死超级细菌
  • 批准号:
    2902040
  • 财政年份:
    2023
  • 资助金额:
    $ 49.5万
  • 项目类别:
    Studentship
STRUCTURAL ANALYSIS OF THE COAT AND GENOMIC RNA OF THE BACTERIAL VIRUS MS2
细菌病毒MS2的外壳和基因组RNA的结构分析
  • 批准号:
    8169688
  • 财政年份:
    2010
  • 资助金额:
    $ 49.5万
  • 项目类别:
STRUCTURAL ANALYSIS OF THE COAT AND GENOMIC RNA OF THE BACTERIAL VIRUS MS2
细菌病毒MS2的外壳和基因组RNA的结构分析
  • 批准号:
    7956460
  • 财政年份:
    2009
  • 资助金额:
    $ 49.5万
  • 项目类别:
Cloning a Head-Size Determinant of the Bacterial Virus P1 (Biology)
克隆细菌病毒 P1 的头部大小决定因素(生物学)
  • 批准号:
    8311047
  • 财政年份:
    1984
  • 资助金额:
    $ 49.5万
  • 项目类别:
    Standard Grant
CONTROL OF RNA SYNTHESIS BY THE BACTERIAL VIRUS LAMBDA
细菌病毒 Lambda 对 RNA 合成的控制
  • 批准号:
    7352514
  • 财政年份:
    1973
  • 资助金额:
    $ 49.5万
  • 项目类别:
CONTROL OF RNA SYNTHESIS BY THE BACTERIAL VIRUS LAMBDA
细菌病毒 Lambda 对 RNA 合成的控制
  • 批准号:
    7351535
  • 财政年份:
    1973
  • 资助金额:
    $ 49.5万
  • 项目类别:
THE CONTROL OF RNA SYNTHESIS BY THE BACTERIAL VIRUS LAMBDA
细菌病毒 Lambda 对 RNA 合成的控制
  • 批准号:
    7137139
  • 财政年份:
    1971
  • 资助金额:
    $ 49.5万
  • 项目类别:
Investigation of the Bacterial Virus Phi SO
细菌病毒 Phi SO 的调查
  • 批准号:
    680F293
  • 财政年份:
    1968
  • 资助金额:
    $ 49.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了